Cory Williams

Cory Williams, MD, PhD, is the Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, Inc., where they provide strategic direction and leadership for drug development in Rare Diseases. Previously, Cory held leadership roles at Pfizer and McKinsey & Company, managing international clinical development portfolios and directing major strategic programs. With extensive experience across various therapy areas, Cory has successfully led global teams in delivering innovative drug programs and navigating complex regulatory environments. They earned a D.Phil. in Clinical Medicine from the University of Oxford and are currently expanding their knowledge in Cancer Genomics and Precision Oncology at Harvard Medical School.